One year fellowship in FDA's Division of Medication Error Prevention and Analysis
The Network for Excellence in Health Innovation estimates that outpatient and inpatient preventable medication errors have an annual cost of nearly $21 billion. There exists a need to enhance FDA’s pharmacovigilance program to identify and prevent errors associated with CDER-regulated products. The fellow’s research will focus on developing innovative surveillance and analytical approaches for CDER-regulated drug products. The fellow may also identify and complete a research project on evaluating the utility of data mining or other predictive analytics for medication error surveillance, determine the effectiveness of regulatory interventions to prevent medication errors, and advance the regulatory science of post-market training programs for medication error prevention and analysis.
1 year of post-PharmD experience strongly preferred
About US Food & Drug Administration
The Food and Drug Administration is the premier scientific regulatory agency responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable, as well as publishing accurate, science-based information the public needs in order to use medicines and foods to improve their health.